OrganoClick (ORGC) Q3 2025 earnings summary

Executive summary

• Net sales for Q3 2025 were SEK 22.5 million, down 22.2% year-over-year, with EBIT at SEK -6.4 million and EPS at SEK -0.08.

• Sales declines were mainly due to lower volumes from the two largest customers and shifts in delivery plans.

• A new share issue and shareholder loan raised SEK 31 million, strengthening liquidity.

• Efficiency programs launched are expected to reduce annual costs by SEK 18 million when fully implemented.

Financial highlights

• Q3 net sales: SEK 22,465 thousand (down from SEK 28,882 thousand year-over-year).

• Q3 EBIT: SEK -6,416 thousand (vs. SEK -3,005 thousand last year).

• Gross margin for Q3: 17.5% (down from 23.0%).

• Cash flow from operating activities Q3: SEK -8,476 thousand.

• Earnings per share Q3: SEK -0.08 (vs. SEK -0.05 last year).

Outlook and guidance

• Signs of increasing demand from both existing and new customers for green products.

• Cost reduction programs expected to improve profitability in 2026.

• Strategic focus on European expansion and new product launches in nonwoven applications.